Tag Archives: Her2

Breast and Endometrial Cancer – Causes, Symptoms, Diagnosis, Prognosis and Hormonal Treatment

Posted on November 27, 2010 by wngai

Breast Cancer  Breast cancer is the most commonly diagnosed cancer in women and the second leading cause of cancer death in the United States.  It is estimated that the lifetime risk of developing breast cancer is one in eight, with … Continue reading →

Posted in Breast cancer, Cancer, Endometrial Cancer | Tagged , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , | 1 Comment

HER2-positive Breast Cancer with Brain Metastases? Use Lapitinibi (Tykerb) and Capecitibine (Xeloda) but NOT Trastuzumab (Herceptin)

Posted on September 27, 2010 by wngai

Human epidermal growth factor receptor 2-positive (HER2+) breast cancer (BC) is a disease that accounts for up to one third of all invasive breast tumors. The natural history of this disease, however, has been dramatically improved with the introduction of … Continue reading →

Posted in Breast cancer, Cancer | Tagged , , , , , , , , , , | Comments Off on HER2-positive Breast Cancer with Brain Metastases? Use Lapitinibi (Tykerb) and Capecitibine (Xeloda) but NOT Trastuzumab (Herceptin)

Good News for Women Who Have HER2-Positive, Herceptin-resistant, Metastatic Breast Cancer

Posted on February 27, 2010 by wngai

A study published in the March issue of the Journal of Clinical Oncology indicated that breast cancer patients who have HER2/neu gene, but have failed Herceptin therapy, can now receive Tykerb, in addition to their Hercpetin, to improve their length of time … Continue reading →

Posted in Breast cancer, Cancer | Tagged , , , , , | Comments Off on Good News for Women Who Have HER2-Positive, Herceptin-resistant, Metastatic Breast Cancer